(Q71820044)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Inhibition of carnitine biosynthesis by valproic acid in rats--the biochemical mechanism of inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

V Farkas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

I Bock

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J Cseko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A Sandor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

English

0 references

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1429-1433

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

Carnitine metabolism and inborn errors

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Pivampicillin-promoted excretion of pivaloylcarnitine in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Impaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Carnitine metabolism in valproate-treated rats: the effect of L-carnitine supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Effects of acute valproate administration on carnitine metabolism in mouse serum and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Alterations of urinary acetylcarnitine in valproate-treated rats: the effect of L-carnitine supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

L-carnitine replacement therapy in chronic valproate treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

A method for the determination of carnitine in the picomole range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

An enzymatic method for the determination of butyrobetaine via conversion to carnitine after isolation by high performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Use of anion-exchange resin in F- form in sample processing for determination of carnitine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Butyrobetaine availability in liver is a regulatory factor for carnitine biosynthesis in rat. Flux through butyrobetaine hydroxylase in fasting state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Mitochondrial metabolism of valproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900507-2

10.1016/S0006-2952(96)00507-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8937454%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference